Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. [PDF]
Mingione A +11 more
europepmc +1 more source
Fracture Risk Associated With Dimethyl Fumarate Treatment in Multiple Sclerosis Patients: Population Heterogeneity and Temporal Patterns. [PDF]
He D +6 more
europepmc +1 more source
Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy. [PDF]
Camelo S.
europepmc +1 more source
The Age-Related Efficacy of Dimethyl Fumarate in Naive Versus Switcher Multiple Sclerosis Patients: A Multicenter Population-Based Study. [PDF]
De Masi R, Orlando S, Greco A, Costa MC.
europepmc +1 more source
Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway. [PDF]
Jiang H +17 more
europepmc +1 more source
Omaveloxolone, But Not Dimethyl Fumarate, Improves Cardiac Function in Friedreich's Ataxia Mice With Severe Cardiomyopathy. [PDF]
Salinas L +6 more
europepmc +1 more source
The combination of venetoclax with dimethyl fumarate synergistically induces apoptosis in AML cells by disrupting mitochondrial integrity through ROS accumulation. [PDF]
Kawaguchi SI +9 more
europepmc +1 more source
Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2. [PDF]
Kosinska J +18 more
europepmc +1 more source
Dimethyl Fumarate Reverses β-Adrenoceptor-Mediated Myocardial Fibrosis in Mice by Inhibiting Yes-Associated Protein-Regulated Expression of Intermediate-Conductance Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel in Fibroblasts. [PDF]
Wu LH +12 more
europepmc +1 more source

